Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review)

  • Authors:
    • Xiaoting Sun
    • Qi Li
  • View Affiliations

  • Published online on: June 26, 2018     https://doi.org/10.3892/ijmm.2018.3744
  • Pages: 1203-1214
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Prostaglandin E2 (PGE2) receptor 2 subtype (EP2), which is a metabolite of arachidonic acid that binds with and regulates cellular responses to PGE2, is associated with numerous physiological and pathological events in a wide range of tissues. As a stimulatory G protein‑coupled receptor, PGE2‑induced EP2 activation can activate adenylate cyclase, leading to increased cytoplasmic cAMP levels and activation of protein kinase A. The EP2 receptor can also activate the glycogen synthase kinase 3β and β‑catenin pathways. The present study aimed to review the roles of the EP2 receptor in tumor development, including immunity, chronic inflammation, angiogenesis, metastasis and multidrug resistance. Furthermore, the involvement of the EP2 receptor signaling pathway in cancer was discussed. Understanding the role and mechanisms of action of the EP2 receptor, and its importance in targeted therapy, may help identify novel methods to improve management of numerous types of cancer.
View Figures
View References

Related Articles

Journal Cover

September-2018
Volume 42 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun X and Li Q: Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review). Int J Mol Med 42: 1203-1214, 2018.
APA
Sun, X., & Li, Q. (2018). Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review). International Journal of Molecular Medicine, 42, 1203-1214. https://doi.org/10.3892/ijmm.2018.3744
MLA
Sun, X., Li, Q."Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review)". International Journal of Molecular Medicine 42.3 (2018): 1203-1214.
Chicago
Sun, X., Li, Q."Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review)". International Journal of Molecular Medicine 42, no. 3 (2018): 1203-1214. https://doi.org/10.3892/ijmm.2018.3744